The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.

MOE NPSfinder® QSAR computational models designer benzodiazepines docking web crawler

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
26 Jul 2021
Historique:
received: 15 07 2021
revised: 19 07 2021
accepted: 20 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 29 8 2021
Statut: epublish

Résumé

Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics. Here, computational models (i.e., quantitative structure-activity relationship/QSAR and Molecular Docking) were used to analyse DBZDs identified online by an automated web crawler (NPS

Identifiants

pubmed: 34451817
pii: ph14080720
doi: 10.3390/ph14080720
pmc: PMC8398354
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Psychother Psychosom. 2020;89(5):274-282
pubmed: 32615566
Hum Psychopharmacol. 2017 May;32(3):
pubmed: 28657187
Int J Legal Med. 2017 Jul;131(4):979-988
pubmed: 28160051
Mol Divers. 2002;5(4):231-43
pubmed: 12549674
J Appl Toxicol. 2012 Nov;32(11):880-9
pubmed: 22886396
J Med Chem. 2007 Jun 14;50(12):2875-85
pubmed: 17521177
J Mol Graph Model. 2002 Jan;20(4):269-76
pubmed: 11858635
J Cheminform. 2013 Jan 24;5(1):7
pubmed: 23343401
Sci Justice. 2018 May;58(3):219-225
pubmed: 29685303
Drug Test Anal. 2018 Jan;10(1):37-53
pubmed: 28471096
J Psychopharmacol. 2020 Sep;34(9):1021-1029
pubmed: 31971477
J Comput Aided Mol Des. 2007 Apr;21(4):145-53
pubmed: 17203365
Nature. 2019 Jan;565(7740):454-459
pubmed: 30602790
Molecules. 2018 Aug 30;23(9):
pubmed: 30200181
Hum Psychopharmacol. 2015 Jul;30(4):302-18
pubmed: 26216567
J Chem Inf Model. 2010 Jul 26;50(7):1189-204
pubmed: 20572635
J Chem Inf Model. 2014 Jan 27;54(1):1-4
pubmed: 24251851
J Med Toxicol. 2013 Jun;9(2):155-62
pubmed: 23404347
Pharmaceuticals (Basel). 2021 Jun 11;14(6):
pubmed: 34208284
Neuropharmacology. 2016 Jun;105:630-638
pubmed: 26686391
Psychol Med. 2021 Jan;51(1):30-42
pubmed: 31327332
J Chem Inf Model. 2019 Sep 23;59(9):3968-3980
pubmed: 31403793
World Psychiatry. 2015 Feb;14(1):15-26
pubmed: 25655145
Sci Rep. 2019 Feb 19;9(1):2268
pubmed: 30783122
Curr Comput Aided Drug Des. 2018;14(2):152-159
pubmed: 29332601
Curr Neuropharmacol. 2020;18(10):966-1051
pubmed: 32116194
J Chem Inf Model. 2015 Jul 27;55(7):1316-22
pubmed: 26099013
Int J Mol Sci. 2019 May 10;20(9):
pubmed: 31083294
J Cheminform. 2015 May 20;7:20
pubmed: 26052348
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6754-63
pubmed: 17980589
J Comput Chem. 1999 May;20(7):720-729
pubmed: 34376030
Exp Neurol. 2021 May;339:113638
pubmed: 33571533
Trends Neurosci. 2011 Apr;34(4):188-97
pubmed: 21353710
Br J Clin Pharmacol. 2020 Mar;86(3):410-419
pubmed: 31674690
Mol Inform. 2010 Jul 12;29(6-7):476-88
pubmed: 27463326
J Neurochem. 1998 May;70(5):2188-94
pubmed: 9572307
Br J Pharmacol. 2002 Jan;135(1):248-56
pubmed: 11786501
Front Psychiatry. 2021 Feb 09;11:632405
pubmed: 33633599
Beilstein J Org Chem. 2016 Dec 12;12:2694-2718
pubmed: 28144341
Trends Pharmacol Sci. 2018 Jul;39(7):659-671
pubmed: 29716746
Curr Neuropharmacol. 2020;18(9):809-837
pubmed: 31933443
Handb Exp Pharmacol. 2018;252:383-410
pubmed: 30367253
ACS Sustain Chem Eng. 2021 Mar 15;9(10):3909-3919
pubmed: 34239782
J Med Chem. 1995 Feb 17;38(4):715-24
pubmed: 7861419
Curr Neuropharmacol. 2017;15(5):731-737
pubmed: 27834144
Curr Top Med Chem. 2011;11(2):241-6
pubmed: 21189125
Ochsner J. 2013 Summer;13(2):214-23
pubmed: 23789008
Eur J Med Chem. 2018 Feb 25;146:171-184
pubmed: 29407948
Trends Pharmacol Sci. 2015 Feb;36(2):78-95
pubmed: 25543280
Chemosphere. 2006 Mar;63(1):99-108
pubmed: 16153688
Clin Pharmacol Drug Dev. 2019 Apr;8(3):266-269
pubmed: 30730611
Hum Psychopharmacol. 2013 Jul;28(4):317-23
pubmed: 23881879
Front Neurosci. 2020 Mar 18;14:149
pubmed: 32256304
Clin Toxicol (Phila). 2019 Apr;57(4):282-286
pubmed: 30430874
Nature. 2010 Feb 11;463(7282):769-74
pubmed: 20148031
Bioorg Med Chem. 2005 Aug 1;13(15):4597-621
pubmed: 15951183
Nature. 1999 Oct 21;401(6755):796-800
pubmed: 10548105

Auteurs

Valeria Catalani (V)

Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, School of Life & Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield AL10 9AB, UK.

Michelle Botha (M)

Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, School of Life & Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield AL10 9AB, UK.

John Martin Corkery (JM)

Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, School of Life & Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield AL10 9AB, UK.

Amira Guirguis (A)

Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, School of Life & Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield AL10 9AB, UK.
Department of Pharmacy, Swansea University Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Singleton Campus, Wales SA2 8PP, UK.

Alessandro Vento (A)

Department of Mental Health, ASL Roma 2, 00182 Rome, Italy.
Addictions' Observatory (ODDPSS), 00141 Rome, Italy.
Department of Psychology, Guglielmo Marconi University, 00193 Rome, Italy.

Norbert Scherbaum (N)

LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, 45147 Essen, Germany.

Fabrizio Schifano (F)

Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, School of Life & Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield AL10 9AB, UK.

Classifications MeSH